CIK: 0001586444
Total reported value
$146.8M
Reporting period: 2017-06-30 · Number of holdings: 20
BLUE JAY CAPITAL MANAGEMENT, LLC disclosed 20 holdings in its latest 13F filing for the period ending 2017-06-30, with total reported value of $146.8M and a quarterly turnover rate of 95.2%.
Browse other institutions with $100M to $1B AUMBrowse other institutions starting with "B"
Blue Jay Capital Management, LLC's disclosed holdings carry a Herfindahl concentration index of 0.052 — mathematically equivalent to about 19 equally-sized positions, close to its 20 actual disclosed holdings. Value is spread relatively evenly across the portfolio rather than concentrated in a handful of names.
Position sizes are fairly uniform across the portfolio (a coefficient of variation of 0.20), suggesting a disciplined, rules-based approach to how much capital goes into each idea.
No strong tilt toward either adding to existing winners or initiating outsized new positions was observed in the latest reported quarter.
Sector classification currently covers about 6% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
Add CLVSEUR
-33.9% -$272.0K
Add INCY
+3.4% -$242.0K
Add N96617118
+4.7% -$720.0K
Add BMRN
-10.0% -$639.0K
Add EW
-25.3% -$512.0K
Add PRAH
-23.9% -$1.1M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | T8S | Tesaro INC | Stock-Other | 6.43% | +0.03% | -20.27% | |
| 2 | CLVSEUR | Clovis Oncology INC | Stock-Other | 6.32% | +1.62% | -33.93% | |
| 3 | INCY | Incyte CORP | Stock-Healthcare | 6.18% | +1.60% | +3.41% | |
| 4 | IRWD | Ironwood Pharmaceuticals INC | Stock-Other | 6.05% | +0.39% | -30.37% | |
| 5 | ✓ | Wright Medical Group NV | Stock-Other | 6.00% | +1.32% | +4.66% | |
| 6 | BMRN | Biomarin Pharmaceutical INC | Stock-Healthcare | 5.84% | +1.31% | -10.04% | |
| 7 | PRAH | Pra Health Sciences INC | Stock-Other | 5.45% | +0.96% | -23.89% | |
| 8 | EW | Edwards Lifesciences CORP | Stock-Healthcare | 5.42% | +1.26% | -25.26% | |
| 9 | ABMDEUR | Abiomed INC | Stock-Other | 5.41% | +0.79% | -26.15% | |
| 10 | NVROEUR | Nevro CORP | Stock-Other | 5.33% | +0.72% | +5.00% | |
| 11 | QGEN | Qiagen N.V. | Stock-Healthcare | 4.98% | +4.98% | NEW | |
| 12 | SNN | Smith & Nephew PLC -spon Adr | Stock-Other | 4.75% | +4.75% | NEW | |
| 13 | PTLAEUR | Portola Pharmaceuticals INC | Stock-Other | 4.59% | +4.59% | NEW | |
| 14 | NBIX | Neurocrine Biosciences INC | Stock-Healthcare | 4.55% | +4.55% | NEW | |
| 15 | BKD | Brookdale Senior Living INC | Stock-Other | 4.51% | +4.51% | NEW | |
| 16 | ICLR | ICON Public Limited Company | Stock-Healthcare | 4.22% | +4.22% | NEW | |
| 17 | VRTX | Vertex Pharmaceuticals INC | Stock-Healthcare | 4.06% | -0.25% | -42.36% | |
| 18 | ALGN | Align Technology INC | Stock-Healthcare | 3.47% | +3.47% | NEW | |
| 19 | ILMN | Illumina INC | Stock-Healthcare | 3.25% | +3.25% | NEW | |
| 20 | ISRG | Intuitive Surgical INC | Stock-Healthcare | 3.19% | +3.19% | NEW |
Not enough priced holdings yet to compute performance
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2017-06-30 | 20 | $146.8M | 95 | |
| 2017-03-31 | 21 | $203.4M | 100 | |
| 2016-12-31 | 15 | $165.7M | 100 | |
| 2016-09-30 | 17 | $183.1M | 100 | |
| 2016-06-30 | 14 | $152.3M | 100 | |
| 2016-03-31 | 16 | $156.4M | 100 | |
| 2015-12-31 | 23 | $296.7M | 100 | |
| 2015-09-30 | 18 | $254.6M | 100 | |
| 2015-06-30 | 28 | $371.6M | 97 | |
| 2015-03-31 | 21 | $285.0M | 100 | |
| 2014-12-31 | 23 | $224.3M | 0 |
Blue Jay Capital Management, LLC's most significant position changes for 2017-06-30: Sold out: Biogen INC (BIIB); Sold out: Globus Medical INC - A (GMED); Sold out: Qiagen N.V. (QGEN); Sold out: Bristol-myers Squibb Co (BMY); Sold out: Cr Bard INC (BCRUSD).
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | CLVSEUR | Clovis Oncology INC | +1.6% | -33.93% | Trim |
| 2 | INCY | Incyte CORP | +1.6% | +3.41% | Add |
| 3 | ✓ | Wright Medical Group NV | +1.3% | +4.66% | Add |
| 4 | BMRN | Biomarin Pharmaceutical INC | +1.3% | -10.04% | Trim |
| 5 | EW | Edwards Lifesciences CORP | +1.3% | -25.26% | Trim |
| 6 | PRAH | Pra Health Sciences INC | +1% | -23.89% | Trim |
| 7 | ABMDEUR | Abiomed INC | +0.8% | -26.15% | Trim |
| 8 | NVROEUR | Nevro CORP | +0.7% | +5.00% | Add |
| 9 | IRWD | Ironwood Pharmaceuticals INC | +0.4% | -30.37% | Trim |
| 10 | T8S | Tesaro INC | 0% | -20.27% | Trim |
| 11 | VRTX | Vertex Pharmaceuticals INC | -0.3% | -42.36% | Trim |
| 12 | BIIB | Biogen INC | — | EXIT | Sold out |
| 13 | GMED | Globus Medical INC - A | — | EXIT | Sold out |
| 14 | QGEN | Qiagen N.V. | — | EXIT | Sold out |
| 15 | BMY | Bristol-myers Squibb Co | — | EXIT | Sold out |
| 16 | BCRUSD | Cr Bard INC | — | EXIT | Sold out |
| 17 | NUVAGBP | Nuvasive INC | — | EXIT | Sold out |
| 18 | CELG | Celgene CORP | — | EXIT | Sold out |
| 19 | MDRX | Veradigm INC | — | EXIT | Sold out |
| 20 | QGEN | Qiagen N.V. | — | NEW | New buy |
| 21 | AKRXEUR | Akorn INC | — | EXIT | Sold out |
| 22 | DERMEUR | Dermira INC | — | EXIT | Sold out |
| 23 | SNN | Smith & Nephew PLC -spon Adr | — | NEW | New buy |
| 24 | PTLAEUR | Portola Pharmaceuticals INC | — | NEW | New buy |
| 25 | NBIX | Neurocrine Biosciences INC | — | NEW | New buy |
| 26 | BKD | Brookdale Senior Living INC | — | NEW | New buy |
| 27 | ICLR | ICON Public Limited Company | — | NEW | New buy |
| 28 | ALGN | Align Technology INC | — | NEW | New buy |
| 29 | ILMN | Illumina INC | — | NEW | New buy |
| 30 | ISRG | Intuitive Surgical INC | — | NEW | New buy |
| Period | Filed | Type | EDGAR |
|---|---|---|---|
| 2017-06-30 | 2017-08-11 | 13F-HR | View on EDGAR |
| 2017-03-31 | 2017-05-12 | 13F-HR | View on EDGAR |
| 2016-12-31 | 2017-02-13 | 13F-HR | View on EDGAR |
| 2016-09-30 | 2016-11-10 | 13F-HR | View on EDGAR |
| 2016-06-30 | 2016-08-12 | 13F-HR | View on EDGAR |
| 2016-03-31 | 2016-05-13 | 13F-HR | View on EDGAR |
| 2015-12-31 | 2016-02-12 | 13F-HR | View on EDGAR |
| 2015-09-30 | 2015-11-13 | 13F-HR | View on EDGAR |
| 2015-06-30 | 2015-08-13 | 13F-HR | View on EDGAR |
| 2015-03-31 | 2015-05-13 | 13F-HR | View on EDGAR |
| 2014-12-31 | 2015-02-13 | 13F-HR | View on EDGAR |
Institutions with a similar AUM
CIK 0002008758
Total reported value
$146.7M
67 stks
2026-03-31
AUM within 0.0% of this institution
CIK 0001963478
Total reported value
$146.8M
496 stks
2024-09-30
Stale — no recent filing
AUM within 0.0% of this institution
CIK 0001804116
Total reported value
$146.7M
89 stks
2026-03-31
AUM within 0.1% of this institution
Institutions with overlapping top holdings
CIK 0001594954
Total reported value
$66.4M
229 stks
2017-09-30
Stale — no recent filing
3 of the top 5 holdings overlap, including Incyte CORP
CIK 0000924223
Total reported value
$4.0B
35 stks
2019-03-31
Stale — no recent filing
1 of the top 5 holdings overlap, including Incyte CORP
CIK 0000942257
Total reported value
$296.8M
65 stks
2023-09-30
Stale — no recent filing
1 of the top 5 holdings overlap, including Incyte CORP